Ligand Pharmaceuticals Incorporated
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2015
Total Assets: $503.1M
Liabilities Breakdown FY2015
Total Liabilities: $226.2M
Asset Breakdown
Total Assets: $503.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $97.4M | 19.4% |
| Accounts Receivable | $6.2M | 1.2% |
| Inventory | $1.6M | 0.3% |
| Property, Plant & Equipment | $372.0K | 0.1% |
| Goodwill | $12.2M | 2.4% |
| Intangible Assets | $48.3M | 9.6% |
| Other Assets | $336.9M | 67.0% |
Liabilities Breakdown
Total Liabilities: $226.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.1M | 1.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $222.1M | 98.2% |